Ney Carter Borges: New Trial Highlights IVL as Effective Strategy for Calcified Coronary Lesions
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared a post on LinkedIn about a recent article by Benjamin Honton et al, published in EuroIntervention, adding:
“ICARE OFDI was a multicenter, prospective, randomized non-inferiority trial comparing intravascular lithotripsy (IVL) with rotational atherectomy (RA) for preparation of moderate-to-severe calcified coronary lesions before PCI.
All procedures were guided by optical frequency domain imaging.
In 169 patients:
- RA n=86
- IVL n=83
IVL was non-inferior to RA for the primary imaging endpoint, minimal stent area: 6.0 plus/minus 2.3 square millimeter versus 5.9 plus/minus 2.2 square millimeter, respectively.
Adequate stent expansion was identical in both groups, 65.1 percent versus 65.1 percent, while major strut malapposition was significantly more frequent after RA: 80.2 percent versus 57.8 percent; p=0.002.
Clinically, both strategies had similar procedural safety and very low 12-month target lesion failure: RA 1.2 percent versus IVL 2.4 percent; p=0.61.
Clinical interpretation: IVL appears to be a valid alternative to RA for stable calcified coronary lesions, offering comparable stent expansion and outcomes, with less major malapposition.
However, the trial was relatively small and powered for an imaging endpoint, not hard clinical outcomes.
Larger trials are still needed before declaring IVL superior.”
Title: Intravascular lithotripsy in comparison to rotational atherectomy for calcified lesions: the ICARE OFDI randomised trial
Authors: Benjamin Honton, Pascal Motreff, Jean-Sébastien Mallet, Thomas Hovasse, Matthieu Godin, Guilhem Malclès, Jerome Brunet, Nicolas Meneveau, Pierre Deharo, Benoit Lattuca, Erwan Bressollette, Michael Angioi, Hakim Benamer, Edouard Gerbaud, Bruno Pereira, Vincenzo Cesario, Antoine Poinas, Clémence Laperche, Antoine Sauguet, Géraud Souteyrand, Nicolas Amabile, Nicolas Combaret

Other posts featuring Ney Carter Borges on Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis